Evidence map›Paper›PMID 39575203›Full record

ArticleTherapeutic advances in infectious disease

Social disparities on PrEP use and awareness among sexual and gender minorities using smartphones in India.

Harsh Agarwal, Karin Yeatts, Stephanie R Chung, Jack Harrison-Quintana, Thiago S Torres

Abstract read
In one paragraph

Article in Therapeutic advances in infectious disease. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Harsh AgarwalUNC Gillings School of Global Public Health, Chapel Hill, NC 27599, USA.ORCID https://orcid.org/0000-0001-8506-9039
Karin YeattsUNC Gillings School of Global Public Health, Chapel Hill, NC, USA.
Stephanie R ChungUNC Gillings School of Global Public Health, Chapel Hill, NC, USA.
Jack Harrison-QuintanaGrindr, West Hollywood, CA, USA.
Thiago S TorresInstituto Nacional de Infectología Evandro Chagas, Fundação Oswaldo Cruz (INI-Fiocruz), Rio de Janeiro, Brazil.ORCID https://orcid.org/0000-0002-2557-601X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Pre-exposure prophylaxis (PrEP) is a safe and effective HIV prevention strategy. However, in countries such as India where PrEP is driven by the private healthcare system and there is no centralized reporting, it is unknown which populations benefit from PrEP and which populations are being left behind. Objectives: We examined and characterized PrEP use and awareness among the sexual and gender minorities using smartphones in India and found measures of association of PrEP use. Design: This is a cross-sectional study design. Methods: We used Grindr-a widely used geosocial mobile application-to conduct a national cross-sectional survey in India, including respondents who were 18 years or older and reported sex with men (those who identified as cis-gender females were excluded). We examined overall PrEP awareness and PrEP use, then calculated adjusted prevalence odds ratio and 95% confidence intervals to understand PrEP use correlation with socio-behavioral factors. Results: Out of the total of 3116 eligible participants, 30.3% ( Conclusion: We found overall low awareness and low PrEP use in our cross-sectional sample. PrEP use and awareness were higher among those who belonged to higher-income groups. Including PrEP in existing programmatic interventions by government and NGOs may contribute to PrEP scale-up, which is urgent to stop the HIV epidemic in India.

Indexed as

HIVHIV in Indiapre-exposure prophylaxisPrEP in IndiaPrEP use in Indiasexual reproductive health in India

Identifiers

PMID39575203
PMCPMC11580082

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.